Skip to main content
TipRanks
Go Ultimate75% OFF

Lifecore Biomedical (LFCR) Stock Statistics & Valuation Metrics

154 Followers

Total Valuation

Lifecore Biomedical has a market cap or net worth of $243.36M. The enterprise value is $439.30M.

Market Cap
$243.36M
Enterprise Value
$439.30M

Share Statistics

Lifecore Biomedical has 37,905,846 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
37,905,846
Owned by Insiders
15.99%
Owned by Institutions
30.14%

Financial Efficiency

Lifecore Biomedical’s return on equity (ROE) is 2.17 and return on invested capital (ROIC) is -0.60%.

Return on Equity (ROE)
2.17
Return on Assets (ROA)
-0.13
Return on Invested Capital (ROIC)
-0.60%
Return on Capital Employed (ROCE)
-0.01
Revenue Per Employee
338.91K
Profits Per Employee
-80.60K
Employee Count
382
Asset Turnover
0.56
Inventory Turnover
3.06

Valuation Ratios

The current PE Ratio of Lifecore Biomedical is -3.40. Lifecore Biomedical’s PEG ratio is 0.04.

PE Ratio
-3.40
PS Ratio
2.08
PB Ratio
-3.31
Price to FCF
47.79
Price to Operating Cash Flow
24.85
PEG Ratio
0.04

Income Statement

In the last 12 months, Lifecore Biomedical had revenue of 129.46M and earned -30.79M in profits. Earnings per share was -0.92.

Revenue
129.46M
Gross Profit
40.61M
Operating Income
-1.26M
Pretax Income
-30.21M
Net Income
-30.79M
EBITDA
5.98M
Earnings Per Share (EPS)
-0.92

Cash Flow

In the last 12 months, operating cash flow was 3.05M and capital expenditures -3.15M, giving a free cash flow of -106.28K billion.

Operating Cash Flow
3.05M
Free Cash Flow
-106.28K
Free Cash Flow per Share
0.13

Dividends & Yields

Lifecore Biomedical pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
2.09%
Earnings Yield
-27.73%

Stock Price Statistics

Beta
1.77
52-Week Price Change
-18.63%
50-Day Moving Average
5.79
200-Day Moving Average
5.34
Relative Strength Index (RSI)
63.79
Average Volume (3m)
403.05K

Important Dates

Lifecore Biomedical upcoming earnings date is May 12, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 04, 2026
Next Earnings Date
May 12, 2027
Ex-Dividend Date
―

Financial Position

Lifecore Biomedical as a current ratio of 3.49, with Debt / Equity ratio of -1004.14%

Current Ratio
3.49
Quick Ratio
2.26
Debt to Market Cap
0.45
Net Debt to EBITDA
20.91
Interest Coverage Ratio
-0.05

Taxes

In the past 12 months, Lifecore Biomedical has paid 577.71K in taxes.

Income Tax
577.71K
Effective Tax Rate
-0.02

Enterprise Valuation

Lifecore Biomedical EV to EBITDA ratio is -15.32, with an EV/FCF ratio of 87.09.

EV to Sales
3.80
EV to EBITDA
-15.32
EV to Free Cash Flow
87.09
EV to Operating Cash Flow
45.35

Balance Sheet

Lifecore Biomedical has $17.47M in cash and marketable securities with $142.61M in debt, giving a net cash position of -$125.14M billion.

Cash & Marketable Securities
$17.47M
Total Debt
$142.61M
Net Cash
-$125.14M
Net Cash Per Share
-$3.30
Tangible Book Value Per Share
-$1.28

Margins

Gross margin is 30.33%, with operating margin of -0.37%, and net profit margin of -57.66%.

Gross Margin
30.33%
Operating Margin
-0.37%
Pretax Margin
-57.54%
Net Profit Margin
-57.66%
EBITDA Margin
-24.77%
EBIT Margin
-31.05%

Analyst Forecast

The average price target for Lifecore Biomedical is $6.28, which is 11.43% higher than the current price. The consensus rating is Neutral

Price Target
$6.28
Price Target Upside
2.18% Downside
Analyst Consensus
Neutral
Analyst Count
3
Revenue Growth Forecast
―
EPS Growth Forecast
―

Scores

Smart Score
4
AI Score
52